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ABSTRACT
Objective: To explore the psychosocial determinants
and interhospital variability on a major acute
cardiovascular event (MACE), during follow-up of a
multicenter cohort of patients hospitalised with heart
disease, participating in a nurse-led secondary
prevention programme.
Methods: Outcome data were retrospectively analysed
from 602 cardiac inpatients randomised to
postdischarge standard care (n=296), or home-based
intervention (n=306), with prolonged follow-up of
individualised multidisciplinary support. Baseline
psychosocial profiling comprised depressive status,
health-related quality of life (HRQoL), social isolation
and mild cognitive impairment (MCI). Multivariate
analyses examined the independent correlates of a
composite 2-year MACE rate of all-cause mortality and
unplanned cardiovascular-related hospitalisation,
according to gender.
Results: Participants were aged 70±10 years, 431
(72%) were men and 377 (63%) had coronary artery
disease. During 2-year follow-up, 165 (27%)
participants (114 men, 51 women; p=0.431)
experienced a MACE. Independent correlates of a
MACE in men were depressive status (OR 1.95, 95%
CI 1.06 to 3.58; p=0.032), low physical HRQoL
(OR 0.98, 95% CI 0.96 to 1.00; p=0.027) and
increasing comorbidity (OR 1.14, 95% CI 1.04 to 1.25;
p=0.004). In women, age (OR 1.06, 95% CI 1.02 to
1.12; p=0.008), MCI (OR 2.38, 95% CI 1.09 to 5.18;
p=0.029) and hospital site predicted a MACE (OR 2.32,
95% CI 1.09 to 4.93; p=0.029).
Conclusions: Psychological determinants, cognitive
impairment and responses to secondary prevention are
different for men and women with heart disease and
appear to modulate cardiovascular-specific outcomes.
Early detection of psychosocial factors through routine
screening and gender-specific secondary prevention is
encouraged.
Trial registration number: 12608000014358.
INTRODUCTION
It is well established that psychosocial risk
factors modulate the development of cardio-
vascular disease1 and can have deleterious
effects on outcomes following a cardiac
event.2 There is now a large body of evidence
to show that depression, reduced mental and
physical health-related quality of life
(HRQoL), stress, lack of social support, and
cognitive impairment are highly prevalent in
cardiac populations.2–8 Consequently,
adverse prognoses and elevated healthcare
usage and costs ensue, potentially due to
poor secondary outcomes as a consequence
of adherence to suboptimal treatment.9 10
While supportive interventions in cardiac
patients with depression have been shown to
improve mental health, it is unclear if they
improve cardiovascular outcomes.10
Distinct gender differences in the natural
history of cardiac disease and presentation of
acute cardiac events is apparent,11 with
higher rates of depression, asymptomatic
presentation and cognitive impairment in
women9 than in men.8 However, few studies
have examined the impact of psychosocial
risk factors in determining secondary cardio-
vascular events on a gender-speciﬁc basis.2
We recently completed the multicenter
KEY QUESTIONS
What is already known about this subject?
▸ Psychosocial factors (ie, depression and social
isolation) increase cardiovascular risk and are
associated with adverse prognosis.
What does this study add?
▸ Psychosocial determinants of, and potential
responses to, secondary prevention was mark-
edly different for men and women in a rigor-
ously conducted clinical trial.
How might this impact on clinical practice?
▸ Early detection of important (and potentially
modifiable) psychosocial risk factors via short
screening tools should be routinely performed,
with a potential need to modulate and apply sec-
ondary prevention strategies applied on a
gender-specific basis.
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Young @ Heart Study that examined the beneﬁts of a
nurse-led, home-based secondary prevention interven-
tion (HBI) in a large cohort of cardiac inpatients (most
with coronary artery disease (CAD)).7 Compared to
standard care, patients enrolled in HBI received compre-
hensive proﬁling, and an initial report (with recommen-
dations) was sent to their primary care and specialist
physician for clinical support and follow-up of any urgent
deﬁcits. Our nurse then implemented that plan (expli-
citly guided by expert secondary prevention guidelines)
via a combination of outreached home visits, telephone
follow-up, multidisciplinary support and referrals to
other allied health professionals (depending on clinic
needs). Our most important ﬁnding was that HBI
resulted in a signiﬁcant reduction in cardiovascular-
related events; primarily hospitalisations for men. While
the ﬁndings showed no overall differences between stand-
ard care and HBI, the nurse-facilitated HBI was not bene-
ﬁcial for women. All end points emphasised poorer
health outcomes relative to standard care in women.7
Moreover, hospital site was an independent correlate of
cardiac events in women.7 We therefore postulated that
these ﬁndings were mediated by gender differences in
psychosocial factors and the response to the patient–
nurse interaction (as determined by the hospital site).
Study aims and hypotheses
On the bases of our initial ﬁndings,7 we conducted a
retrospective analysis of the Young @ Heart Study out-
comes to examine the potential role of psychosocial
factors and hospital site differences in determining a
major acute cardiovascular event (MACE), independent
of clinical proﬁle. Speciﬁcally, it was hypothesised that
there would be a differential contribution of psychosocial
factors to subsequent MACE rates of all-cause mortality
and unplanned cardiovascular-related hospitalisation
based on gender. It was further anticipated that gender
differentials would arise from a speciﬁc response to the
study intervention and the nurse–patient interaction (as
determined by the hospital recruitment site).
MATERIALS AND METHODS
Study population
The design and primary outcomes of the Young @
Heart Study have been described previously.7 12
Recruited participants were elective and emergency
inpatients at two hospitals in Brisbane, Australia; private
health insurance holders (Bupa Australia), aged
≥45 years; diagnosed with chronic heart disease (princi-
pally CAD, chronic heart failure and arrhythmia
(chronic atrial ﬁbrillation)), discharged to home and
required long-term management of symptoms and
pharmacotherapy. Ethical approval was obtained from
each administering hospital’s ethics committees, and the
study complied with the Declaration of Helsinki and
CONSORT guidelines for reporting a pragmatic trial.13
All participants gave written informed consent.
Subject profiling
All participants were comprehensively proﬁled by the
Young @ Heart Study nurses using standardised case
report forms and validated assessment tools,12 with infor-
mation gained from a combination of health records
and subject interviews.
Postdischarge management
Participants were randomised (1:1) to receive post-
discharge standard care, or the nurse-led standardised
HBI programme12 delivered by two trained specialist
cardiac nurses from two administering hospitals
(Hospital-A and Hospital-B). In brief, participants who
were randomised to HBI received a comprehensive clin-
ical assessment including an outreach home visit
1–2 weeks postdischarge (baseline), followed by repeat
home visits and phone calls (depending on clinic
needs) as part of an individualised programme of care
(eg, support and appropriate referrals) with a strong
focus on preventing progressive cardiac dysfunction to a
subsequent MACE.
Psychosocial profile
The Patient Health Questionnaire-2 (PHQ-2) was used to
assess the presence of a depressed mood.14 Participants
answered either ‘yes’ or ‘no’ to detect depressed mood
and a loss of interest or pleasure in routine activities. A
positive response to either question triggered further
testing with the Center for Epidemiologic Studies-Depression
Scale (CES-D),15 a reliable self-report questionnaire
designed to identify depressive symptomatology from 20
items addressing how the respondent felt or behaved
during the previous week. A score ≥16 on the CES-D sig-
niﬁes potential depression. The 12-item short-form health
survey was used to assess mental, physical and overall
health related quality of life (HRQoL). Using the ﬁve-
point Likert scale, respondents answered each of the 12
subscales measuring eight domains: (1) physical, (2) role
physical, (3) bodily pain, (4) general health, (5) vitality,
(6) social functioning, (7) emotional role and (8)
mental health.16 The Montreal Cognitive Assessment
(MoCA), was used to identify mild cognitive impairment
(MCI) as deﬁned by a score of <26 of 30.17 Last, assess-
ment of social isolation was determined by household
membership (eg, living alone or with others).
Clinical profile
Extent of each participant’s concurrent comorbidity was
measured using the Charlson Comorbidity Index
adjusted for age.18 Demographic proﬁle, clinical proﬁle
(heart failure classiﬁcation, kidney function, triglycer-
ides, blood glucose) and cardiovascular risk factors
(smoking habit, alcohol risk, cholesterol, body mass
index, diabetes and hypertension), in addition to
disease-speciﬁc proﬁling (eg, extent of CAD), were
recorded from a standard patient assessment form.
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Major acute cardiovascular events
As part of the Young @ Heart Study, all hospitalisations
were subject to blinded adjudication, and classiﬁed
according to the discharge summary and principal diag-
noses documented by the treating clinician. For the
purpose of this study, a MACE was deﬁned as any
unplanned/emergency cardiovascular-related hospital-
isation, or all-cause mortality, during a 2-year follow-up.
Statistical analyses
All study analyses were performed retrospectively using
SPSS (V.22, SPSS Inc, Chicago, Illinois, USA). Data are
presented as mean (±SD) and median (IQR) for nor-
mally and non-normally distributed continuous vari-
ables, respectively. Numbers with percentages in
parentheses are reported for categorical variables.
Independent samples t test and Mann-Whitney U test
were used to compare groups on normally and non-
normally distributed continuous variables, respectively.
Pearson’s χ2 test of independence and OR with 95% CIs
were used to explore categorical variables. Kaplan-Meier
survival curves were generated, and a bivariate log-rank
test calculated to determine whether there were differ-
ences in 2-year MACE (days to ﬁrst event) according to
gender, group randomisation and hospital site.
Multivariate logistic regression analyses (backward elim-
ination) were performed to determine the independent
predictors of MACE for men and women separately.
Independent variables included were baseline psycho-
social factor variables, subject demographics, cardiovas-
cular risk factors, concurrent comorbidity and clinical
characteristics. Statistical signiﬁcance was accepted at
α<0.05 (two-tailed).
RESULTS
Study cohort
A total of 602 participants were assessed, of whom 306
(51%) were randomised to receive the nurse-led HBI.
Mean age of participants was 70±10 years and majority
(n=431, 72%) were men. CAD (63%) was the most
common reason for an index event (71% underwent a
revascularisation procedure), followed by arrhythmia
(20%) and heart failure (7%). From a psychosocial per-
spective, one in ﬁve participants (21%) lived alone, 23%
had potential depressive symptoms (positive PHQ-2),
and 28% had MCI.
Gender profile
Compared to men, women were signiﬁcantly older
(73±10 vs 68±9; p<0.0001) and less likely to have
received a tertiary education (23% vs 44%, OR 0.39; CI
0.26 to 0.59; p<0.0001). They were also more likely to
report potential depressive symptoms (positive PHQ-2:
30% vs 21%, OR 1.61, CI 1.07 to 2.40; p=0.020), have
lower physical HRQoL scores (medium 39 (IQR 38 to
47) vs 46 (IQR 37 to 53); p<0.0001), and live alone
(46% vs 11%, OR 6.5, CI 4.26 to 9.93; p<0.0001).
Cardiovascular events
Overall, 165 patients (27%), experienced at least one
MACE, including 22 (13%) fatal events, with 33 (20%)
and 15 (9%) participants experiencing 2 and ≥3 events,
respectively. The overall study ﬂowchart is presented in
online supplementary ﬁgure A. On average, MACE ﬁrst
occurred at 260±218 days post-index hospitalisation.
Participants who experienced a MACE were signiﬁcantly
older (72±10 vs 69±9; p<0.001), had more comorbidities
(mean Charlson Index 5.7±2.7 vs 4.5±2.3; p=0.001),
reduced physical HRQoL score (medium 39 (IQR 31 to
47) vs 46 (36 to 53); p<0.001) and were more likely to
have MCI (38% vs 25%; p=0.002).
Gender-specific outcomes
There were no signiﬁcant gender differences in the con-
tribution of all-cause deaths or hospitalisations to a
MACE (27% of men vs 30% of women; p=0.431). In
both women and men, the main reason for rehospitali-
sation was acute coronary syndrome (29% vs 36%), fol-
lowed by arrhythmia (20% vs 15%), angina (18% vs
15%), and heart failure (13% vs 12%). Of the 114 men
and 51 women who had a MACE, women were more
likely to suffer from multiple events (39% vs 24%, OR
2.08, 95% CI 1.02 to 4.22; p=0.041).
Table 1 compares event-free status by gender and
according to baseline characteristics. On an unadjusted
basis, men and women who had experienced a MACE
were signiﬁcantly older, had a greater number of
comorbidities and MCI compared with their non-MACE
counterparts. For women only, there were differences in
MACE rates according to the enrolling hospital (and by
implication, the healthcare team applying the study
intervention) with a greater proportion of women from
Hospital-B who had a MACE (38% vs 19%; p=0.006).
Alternatively, in men only, potential depressive symptoms
were associated with a higher MACE rate (p=0.005).
Table 2 displays multivariate variables predicting a
MACE using logistic regression (backward elimination
procedure). Independent correlates of a 2-year MACE,
overall, were higher Chalrson comorbidity, reduced
physical HRQoL and MCI (table 2). When examining
men and women separately, greater comorbidity, low
physical HRQoL and depressive status (positive PHQ-2
plus CES-D score ≥16) were independently associated
with an increased risk of a 2-year MACE in men
(table 2). Conversely, in women, age, MCI at baseline
and Hospital-B were associated with an equivalent
increased risk.
Group management and gender outcomes
Overall, there was no difference in 2-year MACE accord-
ing to group randomisation (82 (28%) standard care
versus 83 (27%) HBI; p=0.874). However, gender-
speciﬁc differences were found in the HBI group with
proportionally more women than men experiencing a
MACE during study follow-up (35% vs 24%, log-rank
χ2=4.5; p=0.034). Alternatively, there were no differences
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Table 1 Baseline characteristics of participants who had an event, or were event-free, in the entire cohort and according to gender
All (N=602) Men (N=431) Women (N=171)
Characteristic Total
Event-free
(N=437)
Event
(N=165) p Value
Event-free
(N=317)
Event
(N=114) p Value
Event-free
(N=120)
Event
(N=51) p Value
Demographic profile
Age (years) 70±10 69±9 72±10 <0.001 68±9 70±10 0.033 71±10 77±8 <0.001
Education >12 years (%) 228 (38) 176 (40) 52 (32) 0.051 145 (46) 43 (38) 0.150 31 (26) 9 (18) 0.247
Study site 0.073 0.713 0.006
Hospital A (%) 258 (43) 197 (76) 61 (24) 137 (74) 47 (26) 60 (81) 14 (19)
Hospital B (%) 344 (57) 240 (70) 104 (30) 180 (73) 67 (27) 60 (62) 37 (38)
Group randomisation 0.874 0.200 0.104
HBI (%) 306 (51) 223 (73) 83 (27) 164 (76) 51 (24) 59 (65) 32 (35)
Standard care (%) 296 (46) 214 (72) 82 (28) 153 (71) 63 (29) 61 (76) 19 (24)
Risk factor profile
BMI >25 kg/m2 (%)* 357 (68) 265 (68) 92 (66) 0.549 201 (72) 67 (69) 0.544 64 (59) 25 (58) 0.948
Total cholesterol (mmol/L) 3.9±1.1 3.9±1.1 3.9±1.1 0.784 3.8±1.1 3.7±1.0 0.377 4.1±1.5 4.3±1.0 0.488
Systolic BP (mm Hg) 139±23 139±23 140±25 0.530 138±23 138±24 0.971 143±23 147±25 0.374
Diastolic BP (mm Hg) 75±12 75±11 73±14 0.072 76±11 74±13 0.176 73±12 71±15 0.294
Type II diabetes (%) 125 (21) 83 (19) 42 (26) 0.081 63 (20) 27 (24) 0.391 20 (17) 15 (29) 0.059
Blood glucose (mmol/L) 5.8 (5.2–6.8) 5.8 (5.2–6.8) 5.9 (5.2–7.0) 0.187 5.8 (5.2–6.8) 5.9 (5.2–6.9) 0.676 5.7 (5.1–6.4) 5.9 (5.2–7.8) 0.079
Current smoker (%) 52 (9) 41 (9) 11 (7) 0.299 31 (10) 11 (10) 0.989 10 (8) 0 0.034
High alcohol risk (%) 114 (19) 90 (21) 24 (15) 0.097 86 (27) 24 (21) 0.218 4 (3) 0 0.187
Clinical presentation
Charlson comorbidity18 4.9±2.5 4.5±2.3 5.7±2.7 <0.001 4.4±2.3 5.4±2.6 <0.001 4.8±2.2 6.3±2.7 <0.001
eGFR<60 mL/min/1.73 m2 (%)† 103 (22) 58 (17) 45 (35) <0.001 35 (14) 28 (31) <0.001 23 (26) 17 (43) 0.053
Functional status
NYHA class II, III, VI (%) 280 (47) 189 (43) 91 (56) 0.006 126 (40) 57 (51) 0.036 63 (53) 34 (67) 0.098
Canadian class II, III, VI (%) 225 (38) 158 (36) 67 (42) 0.244 107 (34) 49 (45) 0.048 51 (43) 18 (35) 0.357
6 min walk test (m)‡ 305±119 312±116 285±126 0.024 328±111 309±117 0.158 268±115 226±127 0.065
Primary diagnosis
Arrhythmia (%) 119 (20) 80 (67) 39 (33) 57 (18) 25 (22) 23 (19) 14 (27)
CAD (%) 377 (63) 289 (66) 88 (53) 220 (70) 65 (57) 69 (58) 23 (45)
Heart failure (%) 45 (7) 33 (8) 12 (7) 14 (4) 7 (6) 19 (16) 5 (10)
PAD (%) 1 (0.2) 1 (0.2) 0 1 (0.2) 0 0 0
Renal disease (%) 5 (0.8) 1 (0.2) 4 (2) 0 2 (2) 1 (1) 2 (4)
Valve disease (%) 17 (3) 10 (2) 7 (4) 9 (3) 5 (4) 1 (1) 2 (4)
Other (%) 37 (6) 22 (5) 15 (9) 15 (5) 10 (9) 7 (6) 5 (10)
Psychosocial factors
Patient lives alone (%) 127 (21) 86 (20) 41 (25) 0.144 36 (11) 13 (12) 0.943 50 (42) 28 (55) 0.112
Quality of life§
SF-12 Physical 43 (34–52) 46 (36–53) 39 (31–47) <0.001 47 (38–53) 41 (33–49) 0.001 40 (30–48) 34 (26–44) 0.080
SF-12 Mental 55 (48–59) 55 (48–59) 26 (24–28) 0.274 56 (49–60) 54 (47–60) 0.333 54 (48–59) 54 (46–58) 0.757
Continued
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for those randomised to standard care according to
gender (24% vs 29%; p=0.313).
Group management by study-site by gender outcomes
There were notable differences in the overall pattern of
2-year MACE according to hospital site (24% from
Hospital-A vs 30% from Hospital-B), however, it was not
statistically signiﬁcant (p=0.073). Proportionately, more
women than men from Hospital-B experienced a
MACE, although this was of borderline signiﬁcance
(38% vs 27%, log-rank χ2=3.8, p=0.052). Further, signiﬁ-
cantly more women from Hospital-A in the standard
care group experienced a MACE (33% vs 12%;
p=0.028). There was a similar (not signiﬁcant) trend in
women receiving HBI (43% vs 25%; p=0.064; ﬁgure 1A)
and no signiﬁcant differences in men (HBI, p=0.553;
standard care, p=0.888; ﬁgure 1B).
Figure 2 shows the log-rank survival curves in
Hospital-A and Hospital-B according to gender and
group randomisation. The 2-year MACE rate for partici-
pants receiving HBI was similar for women and men
enrolled from Hospital-A (22% vs 25%), although there
was a signiﬁcantly higher 2-year MACE rate in men only
(29% vs 12%, p=0.045; ﬁgure 2A). For participants
receiving standard care, there were no signiﬁcant
gender differences observed for Hospital-B (p=0.761).
However, in contrast with Hospital-A, there was a signiﬁ-
cantly higher 2-year MACE rate in women than men in
subjects at Hospital-B (43% vs 25%; ﬁgure 2B).
DISCUSSION
We undertook a post hoc analysis of a nurse-led second-
ary prevention program7 to determine the impact of
psychosocial factors and/or hospital site on 2-year
MACE according to gender. Overall, we found that
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Table 2 Multivariate logistic regression models of
predictors of a 2-year MACE in all patients and according
to gender
Predictor OR (95% CI) p Value
All patients (n=546)
Charlson comorbidity
index
1.15 (1.06 to 1.25) 0.001
SF-12 physical score 0.98 (0.96 to 1.00) 0.020
Mild cognitive impairment 1.53 (1.02 to 2.30) 0.040
Men (n=402)
Charlson comorbidity
index
1.14 (1.04 to 1.25) 0.004
SF-12 physical score 0.98 (0.96 to 1.00) 0.030
Potential depression* 1.95 (1.06 to 3.58) 0.030
Women (n=162)
Age 1.06 (1.02 to 1.12) 0.008
Mild cognitive impairment 2.38 (1.09 to 5.18) 0.030
Study-site (hospital-B) 2.32 (1.09 to 4.93) 0.030
*Positive PHQ-2 plus CES-D ≥16.
Bold value was statistically significant at <0.05.
SF-12, 12-item short-form score.
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more women than men experienced a MACE. Increasing
comorbidity, reduced physical HRQoL and MCI inde-
pendently predicted a 2-year MACE. In men only, inde-
pendent correlates of a MACE were reduced physical
HRQoL, increasing comorbidity and depressive status,
whereas independent correlates for women were hospital
site, older age and MCI. We found a markedly different
response to the HBI in women from one recruitment
hospital only. These ﬁndings suggest that, independent
of clinical proﬁle, different psychosocial factors contrib-
ute to a 2-year MACE in men and women exposed to a
secondary prevention programme for cardiovascular
disease. Additionally, patient–nurse interaction, particu-
larly in women, may inﬂuence the way patients respond
to the programme delivered in the home.
Findings from the current study support the hypoth-
esis that in a sample of predominantly CAD patients, psy-
chosocial factors can differentially inﬂuence secondary
cardiovascular outcomes in men and women. Our ﬁnd-
ings also agree with previous research to show that those
cardiac patients with psychosocial risk factors including
depressive symptoms,3 4 reduced physical but not mental
HRQoL,5 and impaired cognitive function8 19 have
poorer outcomes and greater mortality risk. Moreover,
we have further demonstrated gender-speciﬁc psycho-
social risk factors. The ﬁnding that women, overall, who
had a 2-year MACE, were more likely to have MCI, is
congruent with previous research demonstrating that
MCI predicts health outcomes and mortality.8 19 This
may be explained by a limited ability to comprehend
and adhere to medical treatments as a result of greater
cognitive impairement.8 It is possible that MCI as a pre-
dictor of a 2-year MACE in women may have been inﬂu-
enced by a combination of factors including old age,
more likely to be living alone and depressed, which is
common among cardiac patients with MCI.9
As with previous studies, we found more depressive
symptoms in women than men;9 20 however, men with
depressive symptoms were almost twice more likely to
have a MACE. It is possible that men with depressive
symptoms in our study beneﬁted from the additional
support provided in HBI leading to improved mood,
lower inﬂammation21 and fewer adverse events.
Moreover, the ﬁnding that reduced physical, but not
mental HRQoL also predicted a MACE in men supports
earlier studies in cardiac patients.5 It is possible that the
Figure 1 Kaplan-Meier event-free survival from a major acute cardiovascular event in women (A) and men (B), according to
group randomisation and hospital enrolment.
Figure 2 Kaplan-Meier event-free survival from a major acute cardiovascular event in patients recruited from Hospitals A (A)
and B (B), according to group randomisation and gender.
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contributing factors of a MACE for men might be psycho-
logical, since depressed cardiac patients were more likely
to report worse physical HRQoL than non-depressed
patients,22 and as observed in men in our current study.
Contrary to previous studies,2 23 social isolation did not
predict a 2-year MACE according to gender, suggesting
that social isolation is a non-gender-speciﬁc predictor of a
secondary cardiac event.2 7
We found that the patient–nurse interaction, as
reﬂected by hospital site, predicted a 2-year MACE. The
ﬁnding that women did not acquire the same beneﬁt at
one hospital, even after adjusting for clinical character-
istics and psychosocial factors, further supports our
initial ﬁndings.7 Differential outcomes were seen
between hospital sites, despite controlling for treatment
ﬁdelity by conducting intensive, standardised, prestudy
and ongoing training for the two cardiac nurses who
delivered the HBI programme at respective hospitals.
One explanation may be due to confounding factors
impacting beyond intervention ﬁdelity (eg, personality,
beliefs, attitudes) of trained personnel delivering the
intervention. Moreover, unequal patient numbers (130
patients in Hospital-A vs 176 patients in Hospital-B)
might cause an unbalanced/overwhelming caseload
management for Hospital-B. Recruitment of additional
nurses in future studies, especially for busier sites, may
alleviate the potentially high work load on these nurses.
Taken together, our ﬁndings support earlier work dem-
onstrating that women may respond differently than
men to HBI.24
These observations are important as they present a
need to re-evaluate current secondary prevention pro-
grammes by addressing gender differences in psycho-
social and cognitive factors associated with increased risk
of future cardiac events. Through prompt intervention to
eliminate/reduce the psychosocial risks (particularly
depression and diminished physical HRQoL in men) and
cognitive impairment (especially for women) detected
via routine screening using brief measures as per HBI,
there is potential to prevent adverse health outcomes in
cardiac patients. Future studies are required to test this
hypothesis. Collectively, these ﬁndings support a collab-
orative care approach where appropriate referral can be
initiated when necessary, linking patients with cardiovas-
cular and mental health clinicians so that patients at risk
of MACEs can receive early intervention of tailored,
gender-speciﬁc, integrated treatments and lifestyle modi-
ﬁcations.6 20 One unique aspect of nurse-led programmes
is not only recommended routine screening for depres-
sion following a cardiac event25 26 but also other pertin-
ent psychosocial risk factors including HRQoL, social
isolation, and cognitive impairment.
Nurse-led, multidisciplinary, home-based disease man-
agement programmes have shown to improve recovery
and reduce hospitalisations in cardiac patients,27 28 prin-
cipally in men but not women.7 However, evidence for
the way in which psychosocial risk factors modulate how
patients respond to secondary prevention programmes,
especially for gender, are limited.2 Our study has
attempted to address this issue by providing a greater
understanding of the differential gender effects of
nurse-led HBIs. Consequently, our ﬁndings reinforce the
need for a ‘patient-centred’ approach to secondary pre-
vention29 with a major consideration of the potentially
different needs of men and women. Simultaneously,
they are a timely reminder of ‘operator dependence’ in
applying complex disease-management interventions
with the potential to trigger a ‘clinical cascade’ that can
provoke more hospital activity.30 However, this is a hypo-
thetical construct and needs to be tested in future
studies. Additionally, over-reporting by women who may
be more attentive to their symptoms, and possible
under-reporting by men may explain the gender differ-
ences. Furthermore, anxiety and stress, especially
job-related stressors, are factors related to poor health
outcomes,2 9 however, we did not measure these, so
future studies exploring these possible links are war-
ranted. Future research exploring cardiac management
programmes that are gender-speciﬁc and tailored to the
individual, by way of addressing psychosocial risk using
brief screening measures to proﬁle patients, and factors
inﬂuencing patient compliance such as the response to
personalised care are urgently required.
A number of limitations inﬂuence the cautious inter-
pretation of these data. First, this was a post hoc analysis,
and we did not prospectively proﬁle patients from a psy-
chosocial perspective in anticipation of the initial ﬁnd-
ings. Additionally, the selective choice of only two
hospitals and recruitment of privately insured patients
who are likely to have higher education and income
levels may bias results. The cohort tested were predom-
inantly patients hospitalised with CAD, however, a sensi-
tivity analysis indicated there were no differences in the
outcomes seen in the pooled cohort. Furthermore, we
acknowledge the risk of multiple testing and the risk of
type I error, and future studies are therefore needed to
replicate our results. Additionally, secondary prevention
medication adherence was not accounted for as possible
predictors, which may have inﬂuenced event rates.
Finally, with the analyses being exploratory, results from
this trial need to be conﬁrmed in larger hypothesis-
driven clinical studies.
CONCLUSION
These data, from a large nurse-led, multidisciplinary, sec-
ondary prevention programme further support the
hypothesis that the psychosocial proﬁle of acute cardiac
patients who experience a MACE differs between men
and women. Notably, overall depressive status and phys-
ical HRQoL was a signiﬁcant predictor of a MACE in
men, and MCI and administering hospital in women.
This study has demonstrated that screening cardiac
patients according to psychosocial risk and ongoing
monitoring can predict poor health outcomes. Also,
who delivers the intervention is another important
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factor as this will have an impact on how the patient ben-
eﬁts from the intervention. Future research exploring
cardiac management programmes that are tailored to
such proﬁling, particularly on a gender-speciﬁc basis,
given an apparently differential response to more perso-
nalised care, are required. Finally, these data have
important implications for the delivery of such care, to
ensure intervention ﬁdelity, and that secondary preven-
tion is appropriately tailored to the patient according to
individual responses to this care.
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